Potential value of cartilage and bone soluble biomarkers in evaluating joint damage in juvenile idiopathic arthritis

por Pederzoli, Silvia, Cangemi, Giuliana, Pistorio, Angela, Gatti, Cinzia, Consiglieri, Giulia, Dellepiane, Marta, Beleva, Diliana, Buoncompagni, Antonella, Martini, Alberto, Malattia, Clara
Publicado em 2014

Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized co...

por Malattia, Clara, Ruperto, Nicolino, Pederzoli, Silvia, Palmisani, Elena, Pistorio, Angela, Wouters, Carine, Dolezalova, Pavla, Flato, Berit, Garay, Stella, Giancane, Gabriella, Wells, Chris, Douglass, Wendy, Brunner, Hermine I., De Benedetti, Fabrizio, Ravelli, Angelo
Publicado no Arthritis Res Ther (2020)

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis

por Bava, Cecilia, Mongelli, Federica, Pistorio, Angela, Bertamino, Marta, Bracciolini, Giulia, Dalprà, Sara, Davì, Sergio, Lanni, Stefano, Muratore, Valentina, Pederzoli, Silvia, Rosina, Silvia, Schiappapietra, Benedetta, Suffia, Chiara, Varnier, Giulia, Verazza, Sara, Giancane, Gabriella, Consolaro, Alessandro, Ravelli, Angelo
Publicado no Pediatr Rheumatol Online J (2019)